Literature DB >> 16901576

Insulin resistance and HCV: will new knowledge modify clinical management?

Francesco Negro1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16901576     DOI： 10.1016/j.jhep.2006.07.011

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  10 in total

1.  Individualizing HCV Treatment with Peginterferon and Ribavirin: What needs to be Done?

Authors:  Donald M Jensen
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

2.  Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.

Authors:  Armanda Casrouge; Jérémie Decalf; Mina Ahloulay; Cyril Lababidi; Hala Mansour; Anaïs Vallet-Pichard; Vincent Mallet; Estelle Mottez; James Mapes; Arnaud Fontanet; Stanislas Pol; Matthew L Albert
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

3.  Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis.

Authors:  Cho Naing; Joon Wah Mak; Syed Imran Ahmed; Mala Maung
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

4.  Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.

Authors:  Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

5.  Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir.

Authors:  V Borghi; L Bisi; L Manzini; A Cossarizza; C Mussini
Journal:  Infection       Date:  2012-12-09       Impact factor: 3.553

Review 6.  Molecular mechanisms of insulin resistance in chronic hepatitis C.

Authors:  Mark W Douglas; Jacob George
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

Review 7.  Hepatitis C virus and type 2 diabetes.

Authors:  Francesco Negro; Mahnaz Alaei
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

8.  Association of hepatitis C virus with insulin resistance: evidences from animal studies and clinical studies.

Authors:  Sadaf Badar; Bushra Khubaib; Muhammad Idrees; Abrar Hussain; Zunaira Awan; Sadia Butt; Samia Afzal; Madeeha Akram; Zareen Fatima; Mahwish Aftab; Sana Saleem; Sara Munir; Bisma Rauff; Mahrukh Naudhani; Liaquat Ali; Muhammaad Ali; Irshadul Rehman
Journal:  Hepat Mon       Date:  2012-01-20       Impact factor: 0.660

9.  Distinct patterns of the lipid alterations between genotype 1 and 2 chronic hepatitis C patients after viral clearance.

Authors:  Ming-Ling Chang; Yung-Kuan Tsou; Tsung-Hui Hu; Cheng-Hui Lin; Wey-Ran Lin; Chang-Mu Sung; Tsung-Hsing Chen; Mei-Ling Cheng; Kuo-Chin Chang; Cheng-Tang Chiu; Chau-Ting Yeh; Jong-Hwei Su Pang; Ming-Shi Shiao
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

10.  Hepatitis C virus infection protein network.

Authors:  B de Chassey; V Navratil; L Tafforeau; M S Hiet; A Aublin-Gex; S Agaugué; G Meiffren; F Pradezynski; B F Faria; T Chantier; M Le Breton; J Pellet; N Davoust; P E Mangeot; A Chaboud; F Penin; Y Jacob; P O Vidalain; M Vidal; P André; C Rabourdin-Combe; V Lotteau
Journal:  Mol Syst Biol       Date:  2008-11-04       Impact factor: 11.429
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.